https://doi.org/10.1186/cc10002
H
Hung-Sheng Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
445
Citations
12
h-index
14
i10-index
Hung-Sheng Lin is an academic researcher from National Taipei University of Technology. The author has contributed to research in topics: Acute Ischemic Stroke Management & Spinal Dysraphism and Malformations & Botulinum Toxin and Related Neurological Disorders. The author has an h-index of 12, co-authored 34 publications.
Papers by this author
worksEffect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke
2011 · Critical Care · 106 citations
Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin
2012 · Journal of Translational Medicine · 21 citations
https://doi.org/10.1186/1479-5876-10-6
Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients—A randomized, open-label, controlled phase II clinical trial
2024 · Stem Cell Research & Therapy · 4 citations
https://doi.org/10.1186/s13287-024-04021-7
Additional benefits of combined ceftriaxone and adipose-derived mesenchymal stem cells on revamping the outcomes in rodent after acute spinal infection
2025 · Journal of Molecular Histology · 0 citations
https://doi.org/10.1007/s10735-024-10344-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat